{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:18:40Z","timestamp":1778685520281,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2022017"],"award-info":[{"award-number":["2022017"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00520-026-10625-x","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:59:26Z","timestamp":1775699966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-reported late effects and chronic fatigue, information needs and follow-up in long-term survivors of Hodgkin lymphoma\u2014a cross-sectional study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6057-2211","authenticated-orcid":false,"given":"Lise H.","family":"Willumsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-4032","authenticated-orcid":false,"given":"Knut B.","family":"Smeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Eikeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4484-9319","authenticated-orcid":false,"given":"Alexander","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne S.","family":"Bersvendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3360-6542","authenticated-orcid":false,"given":"Unn-Merete","family":"Fagerli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8398-3492","authenticated-orcid":false,"given":"Ragnhild S.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne C.","family":"Lie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8974-4764","authenticated-orcid":false,"given":"Tone","family":"Skaali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-185X","authenticated-orcid":false,"given":"Cecilie E.","family":"Kiserud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"Suppl 4","key":"10625_CR1","doi-asserted-by":"publisher","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer DA, Aleman BMP, Andr\u00e9 M, Federico M, Hutchings M, Illidge T et al (2018) Hodgkin lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv19\u2013iv29","journal-title":"Ann Oncol"},{"issue":"3","key":"10625_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.seminhematol.2016.05.008","volume":"53","author":"AK Ng","year":"2016","unstructured":"Ng AK, van Leeuwen FE (2016) Hodgkin lymphoma: late effects of treatment and guidelines for surveillance. Semin Hematol 53(3):209\u2013215","journal-title":"Semin Hematol"},{"issue":"2","key":"10625_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11764-020-00862-2","volume":"14","author":"AG de Boer","year":"2020","unstructured":"de Boer AG, Torp S, Popa A, Horsboel T, Zadnik V, Rottenberg Y et al (2020) Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv 14(2):135\u2013150","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10625_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/0284186X.2023.2168215","volume":"62","author":"SA Eikeland","year":"2023","unstructured":"Eikeland SA, Smeland KB, Simensen VC, Fagerli UM, Bersvendsen HS, Kiserud CE et al (2023) Chronic fatigue in long-term survivors of Hodgkin\u2019s lymphoma after contemporary risk-adapted treatment. Acta Oncol 62(1):80\u201388","journal-title":"Acta Oncol"},{"issue":"10","key":"10625_CR5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","volume":"17","author":"S Kreissl","year":"2016","unstructured":"Kreissl S, Mueller H, Goergen H, Mayer A, Brillant C, Behringer K et al (2016) Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol 17(10):1453\u20131462","journal-title":"Lancet Oncol"},{"issue":"8","key":"10625_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00277-013-1793-2","volume":"92","author":"LA Dani\u00ebls","year":"2013","unstructured":"Dani\u00ebls LA, Oerlemans S, Krol AD, van de Poll-Franse LV, Creutzberg CL (2013) Persisting fatigue in Hodgkin lymphoma survivors: a systematic review. Ann Hematol 92(8):1023\u20131032","journal-title":"Ann Hematol"},{"issue":"5","key":"10625_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/bjh.15448","volume":"182","author":"E Trachtenberg","year":"2018","unstructured":"Trachtenberg E, Mashiach T, Ben Hayun R, Tadmor T, Fisher T, Aharon-Peretz J et al (2018) Cognitive impairment in hodgkin lymphoma survivors. Br J Haematol 182(5):670\u2013678","journal-title":"Br J Haematol"},{"issue":"36","key":"10625_CR8","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1200\/JCO.2016.67.7450","volume":"34","author":"K Behringer","year":"2016","unstructured":"Behringer K, Goergen H, M\u00fcller H, Thielen I, Brillant C, Kreissl S et al (2016) Cancer-related fatigue in patients with and survivors of hodgkin lymphoma: the impact on treatment outcome and social reintegration. J Clin Oncol 34(36):4329\u20134337","journal-title":"J Clin Oncol"},{"issue":"2","key":"10625_CR9","first-page":"116","volume":"68","author":"S Shanbhag","year":"2018","unstructured":"Shanbhag S, Ambinder RF (2018) Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin 68(2):116\u2013132","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10625_CR10","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1200\/JCO.1999.17.12.3736","volume":"17","author":"G Schellong","year":"1999","unstructured":"Schellong G, P\u00f6tter R, Br\u00e4mswig J, Wagner W, Prott FJ, D\u00f6rffel W et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin\u2019s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin\u2019s disease study group. J Clin Oncol 17(12):3736\u20133744","journal-title":"J Clin Oncol"},{"key":"10625_CR11","unstructured":"Medicine Io, Council NR (2006) From cancer patient to cancer survivor: lost in transition. In: Hewitt M, Greenfield S, Stovall E (eds). The National Academies Press,\u00a0Washington, DC, p 534"},{"key":"10625_CR12","unstructured":"Helsedirektoratet. Lymfekreft - handlingsprogram: Helsedirektoratet; 2023 [cited 2023 14.12.]. 7.:[Available from: https:\/\/www.helsedirektoratet.no\/retningslinjer\/lymfekreft-handlingsprogram\/kontroll-oppfolging-og-rehabilitering\/kontrollopplegg-for-ulike-lymfomer."},{"issue":"30","key":"10625_CR13","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1200\/JCO.2012.42.0638","volume":"30","author":"J Ligibel","year":"2012","unstructured":"Ligibel J (2012) Lifestyle factors in cancer survivorship. J Clin Oncol 30(30):3697\u20133704","journal-title":"J Clin Oncol"},{"issue":"11","key":"10625_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2022.07.1941","volume":"33","author":"I Vaz-Luis","year":"2022","unstructured":"Vaz-Luis I, Masiero M, Cavaletti G, Cervantes A, Chlebowski RT, Curigliano G et al (2022) ESMO expert consensus statements on cancer survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol 33(11):1119\u20131133","journal-title":"Ann Oncol"},{"issue":"2","key":"10625_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11764-015-0482-7","volume":"10","author":"IA Syed","year":"2016","unstructured":"Syed IA, Klassen AF, Barr R, Wang R, Dix D, Nelson M et al (2016) Factors associated with childhood cancer survivors\u2019 knowledge about their diagnosis, treatment, and risk for late effects. J Cancer Surviv 10(2):363\u2013374","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10625_CR16","first-page":"e12892","volume":"28","author":"S Christen","year":"2019","unstructured":"Christen S, Weishaupt E, Vetsch J, Rueegg CS, Mader L, Dehler S et al (2019) Perceived information provision and information needs in adolescent and young adult cancer survivors. Eur J Cancer Care (Engl) 28(1):e12892","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"12","key":"10625_CR17","doi-asserted-by":"publisher","first-page":"e7361","DOI":"10.1002\/cam4.7361","volume":"13","author":"IAE de Beijer","year":"2024","unstructured":"de Beijer IAE, Bouwman E, Mulder RL, Steensma P, Brown MC, Ara\u00fajo-Soares V et al (2024) Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: a systematic review. Cancer Med 13(12):e7361","journal-title":"Cancer Med"},{"issue":"9","key":"10625_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/0284186X.2019.1637538","volume":"58","author":"VC Simensen","year":"2019","unstructured":"Simensen VC, Smeland KB, Kiserud CE, Dahl AA, Bersvendsen HS, Fluge \u00d8 et al (2019) Survivors\u2019 knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma. Acta Oncol 58(9):1315\u20131322","journal-title":"Acta Oncol"},{"issue":"5","key":"10625_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/0284186X.2010.550934","volume":"50","author":"SL Hess","year":"2011","unstructured":"Hess SL, J\u00f3hannsd\u00f3ttir IM, Hamre H, Kiserud CE, Loge JH, Foss\u00e5 SD (2011) Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta Oncol 50(5):653\u2013659","journal-title":"Acta Oncol"},{"issue":"7","key":"10625_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/0284186X.2021.1917776","volume":"60","author":"SA Eikeland","year":"2021","unstructured":"Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE et al (2021) Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin\u2019s lymphoma; symptom burden and quality of life. Acta Oncol 60(7):911\u2013920","journal-title":"Acta Oncol"},{"issue":"6","key":"10625_CR21","first-page":"2947","volume":"29","author":"AV Mellblom","year":"2021","unstructured":"Mellblom AV, Kiserud CE, Rueegg CS, Ruud E, Loge JH, Foss\u00e5 SD et al (2021) Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study). Support Care Cancer 29(6):2947\u20132957","journal-title":"Support Care Cancer"},{"issue":"2","key":"10625_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"T Chalder","year":"1993","unstructured":"Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D et al (1993) Development of a fatigue scale. J Psychosom Res 37(2):147\u2013153","journal-title":"J Psychosom Res"},{"issue":"9","key":"10625_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606\u2013613","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10625_CR24","first-page":"230","volume":"72","author":"CL Rock","year":"2022","unstructured":"Rock CL, Thomson CA, Sullivan KR, Howe CL, Kushi LH, Caan BJ et al (2022) American cancer society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin 72(3):230\u2013262","journal-title":"CA Cancer J Clin"},{"key":"10625_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv018","author":"MJ Matasar","year":"2015","unstructured":"Matasar MJ, Ford JS, Riedel ER, Salz T, Oeffinger KC, Straus DJ (2015) Late morbidity and mortality in patients with Hodgkin\u2019s lymphoma treated during adulthood. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv018","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"10625_CR26","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1200\/JCO.20.01186","volume":"39","author":"KC Oeffinger","year":"2021","unstructured":"Oeffinger KC, Stratton KL, Hudson MM, Leisenring WM, Henderson TO, Howell RM et al (2021) Impact of risk-adapted therapy for pediatric Hodgkin lymphoma on risk of long-term morbidity: a report from the childhood cancer survivor study. J Clin Oncol 39(20):2266\u20132275","journal-title":"J Clin Oncol"},{"issue":"8","key":"10625_CR27","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/ijc.34152","volume":"151","author":"ME Schmidt","year":"2022","unstructured":"Schmidt ME, Goldschmidt S, Hermann S, Steindorf K (2022) Late effects, long-term problems and unmet needs of cancer survivors. Int J Cancer 151(8):1280\u20131290","journal-title":"Int J Cancer"},{"key":"10625_CR28","doi-asserted-by":"crossref","unstructured":"Dahl AA, Smeland KB, Eikeland S, Fagerli UM, Bersvendsen HS, Foss\u00e5 A et al (2023) Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects. J Cancer Surviv","DOI":"10.1007\/s11764-023-01432-y"},{"issue":"4","key":"10625_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/bjc.2013.779","volume":"110","author":"LA Dani\u00ebls","year":"2014","unstructured":"Dani\u00ebls LA, Oerlemans S, Krol AD, Creutzberg CL, van de Poll-Franse LV (2014) Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer 110(4):868\u2013874","journal-title":"Br J Cancer"},{"issue":"1","key":"10625_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1186-x","volume":"17","author":"R Busson","year":"2019","unstructured":"Busson R, van der Kaaij M, Mounier N, Aleman BMP, Thi\u00e9blemont C, Stamatoullas A et al (2019) Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study. Health Qual Life Outcomes 17(1):115","journal-title":"Health Qual Life Outcomes"},{"key":"10625_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-020-00311-5","volume":"19","author":"AA Dahl","year":"2020","unstructured":"Dahl AA, Grotmol KS, Hjermstad MJ, Kiserud CE, Loge JH (2020) Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship. Ann Gen Psychiatry 19:60","journal-title":"Ann Gen Psychiatry"},{"issue":"20","key":"10625_CR32","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1200\/JCO.24.00541","volume":"42","author":"JE Bower","year":"2024","unstructured":"Bower JE, Lacchetti C, Alici Y, Barton DL, Bruner D, Canin BE et al (2024) Management of fatigue in adult survivors of cancer: ASCO-Society for integrative oncology guideline update. J Clin Oncol 42(20):2456\u20132487","journal-title":"J Clin Oncol"},{"issue":"6","key":"10625_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218048","volume":"14","author":"N Karavasiloglou","year":"2019","unstructured":"Karavasiloglou N, Pestoni G, Wanner M, Faeh D, Rohrmann S (2019) Healthy lifestyle is inversely associated with mortality in cancer survivors: results from the Third National Health and Nutrition Examination Survey (NHANES III). PLoS One 14(6):e0218048","journal-title":"PLoS One"},{"issue":"41","key":"10625_CR34","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J et al (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J 43(41):4229\u20134361","journal-title":"Eur Heart J"},{"issue":"1","key":"10625_CR35","first-page":"521","volume":"30","author":"L Thorsen","year":"2022","unstructured":"Thorsen L, B\u00f8hn SH, Lie HC, Foss\u00e5 SD, Kiserud CE (2022) Needs for information about lifestyle and rehabilitation in long-term young adult cancer survivors. Support Care Cancer 30(1):521\u2013533","journal-title":"Support Care Cancer"},{"issue":"5","key":"10625_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/0284186X.2018.1558370","volume":"58","author":"HS Bersvendsen","year":"2019","unstructured":"Bersvendsen HS, Haugnes HS, Fagerli UM, Fluge \u00d8, Holte H, Smeland KB et al (2019) Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. Acta Oncol 58(5):690\u2013699","journal-title":"Acta Oncol"},{"issue":"1","key":"10625_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04123-4","volume":"23","author":"K Nakandi","year":"2023","unstructured":"Nakandi K, Benebo FO, Hopstock LA, Stub T, Kristoffersen AE (2023) Adherence to lifestyle recommendations among Norwegian cancer survivors and the impact of traditional and complementary medicine use: the Troms\u00f8 Study 2015-2016. BMC Complement Med Ther 23(1):292","journal-title":"BMC Complement Med Ther"},{"key":"10625_CR38","doi-asserted-by":"crossref","unstructured":"Nilsen L, Hopstock LA, Grimsgaard S, Carlsen MH, Lundblad MW (2021) Intake of vegetables, fruits and berries and compliance to \u201cFive-a-Day\u201d in a general Norwegian population-the Troms\u00f8 study 2015\u20132016. Nutrients","DOI":"10.3390\/nu13072456"},{"key":"10625_CR39","unstructured":"Health NIoP. Low fruit and vegetable consumption (Indicator 16). https:\/\/www.fhi.no\/en\/nc\/Indicators-for-NCD\/diet\/low-fruit-vegetable-consumption-indicator-16\/; 2025."},{"issue":"9","key":"10625_CR40","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/aogs.13855","volume":"99","author":"I Vistad","year":"2020","unstructured":"Vistad I, Lindemann K, Bentzen AG, Dahl AA, Steen R, Kiserud C (2020) Preferences for follow up in long-term survivors after cervical cancer. Acta Obstet Gynecol Scand 99(9):1253\u20131259","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10625_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","volume":"2016","author":"FE van Leeuwen","year":"2016","unstructured":"van Leeuwen FE, Ng AK (2016) Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematol Am Soc Hematol Educ Program 2016(1):323\u2013330","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"10625_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/0284186X.2016.1266091","volume":"56","author":"GM Gjerset","year":"2017","unstructured":"Gjerset GM, Loge JH, Kiserud CE, Foss\u00e5 SD, Gudbergsson SB, Oldervoll LM et al (2017) Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue. Acta Oncol 56(2):245\u2013253","journal-title":"Acta Oncol"},{"issue":"20","key":"10625_CR43","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1200\/JCO.2018.77.7482","volume":"36","author":"PB Jacobsen","year":"2018","unstructured":"Jacobsen PB, DeRosa AP, Henderson TO, Mayer DK, Moskowitz CS, Paskett ED et al (2018) Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol 36(20):2088\u20132100","journal-title":"J Clin Oncol"},{"issue":"23","key":"10625_CR44","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1002\/cncr.34984","volume":"129","author":"RE Hill","year":"2023","unstructured":"Hill RE, Mercieca-Bebber R, Fardell JE, Wakefield CE, Signorelli C, Webber K et al (2023) Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow-up care. Cancer 129(23):3820\u20133832","journal-title":"Cancer"},{"key":"10625_CR45","doi-asserted-by":"publisher","DOI":"10.2196\/55601","volume":"13","author":"EMJ Lammers","year":"2024","unstructured":"Lammers EMJ, Zijlstra JM, Ret\u00e8l VP, Aleman BMP, van Leeuwen FE, Nijdam A (2024) Effectiveness and cost-effectiveness of survivorship care for survivors of Hodgkin lymphoma (INSIGHT study): protocol for a multicenter retrospective cohort study with a quasi-experimental design. JMIR Res Protoc 13:e55601","journal-title":"JMIR Res Protoc"},{"issue":"9","key":"10625_CR46","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.1503\/cmaj.231358","volume":"196","author":"J Shuldiner","year":"2024","unstructured":"Shuldiner J, Sutradhar R, Lau C, Shah N, Lam E, Ivers N et al (2024) Longitudinal adherence to surveillance for late effects of cancer treatment: a population-based study of adult survivors of childhood cancer. CMAJ 196(9):E282\u2013E294","journal-title":"CMAJ"},{"issue":"4","key":"10625_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11764-016-0522-y","volume":"10","author":"PC Nathan","year":"2016","unstructured":"Nathan PC, Agha M, Pole JD, Hodgson D, Guttmann A, Sutradhar R et al (2016) Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv 10(4):611\u2013618","journal-title":"J Cancer Surviv"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10625-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:48:02Z","timestamp":1778683682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10625-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10625"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10625-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Regional Committees for Medical and Health Research Ethics South East (2016\/2311). Informed written consent from all participants in the study was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"414"}}